Matthew Maxwell Donley
CIK 1636642 · Chief Operating Officer · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.76M
Companies
2
Total Filings
24
Lifetime Open-Market Net
-$1.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Chief Operating Officer | 680,299 | $15.82 | $10.76M | -$1.11M | 10 | 2026-03-03 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | EVP, Global HR, IT & Strategy | 36,975 | — | — | $0 | 14 | 2018-02-13 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-16 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +323 | $3.0K | EDGAR |
| 2016-03-04 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +238 | $3.5K | EDGAR |
| 2015-11-20 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +468 | $6.5K | EDGAR |
| 2015-03-16 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.